Clinical Trials Browser

Phase 2/3 × Terminated × Melphalan × Clear all

NCT01907009 2023-04-19

MEL-CAP

Phase 2/3 Terminated

Castrate Resistant Prostate Cancer

NCT00539500 2019-07-26

Autologous Stem Cell Rescue With CD133+ Selected Cells in High-Risk Neuroblastoma

Phase 2/3 Terminated

3 enrolled 4 charts

Neuroblastoma

NCT00176839 2017-12-05

Stem Cell Transplantation for Hematological Malignancies

Phase 2/3 Terminated

11 enrolled 12 charts

LymphoidOther hematologic neoplasm

Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma